The treatment of normal-tension glaucoma

Progress in Brain Research

Volumn 173, Issue , 2008, Pages 195-210

  Desai, Priya V ^a   Caprioli, Joseph ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

acquired pit of optic nerve; calcium channel blockers; central corneal thickness; collaborative normal tension glaucoma study; diagnosis; focal ischemic glaucoma; gene; genetics; glaucoma; intraocular pressure (IOP); low tension glaucoma; migraine; neuroprotection; noncompliance; normal tension glaucoma; NTG; open angle glaucoma; optic disk; optic disk hemorrhage; optic nerve pit; Raynaud's phenomenon; retinal ganglion cells; senile sclerotic glaucoma; treatment; vascular dysfunction; vasospasm; visual field

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MEMANTINE; NIFEDIPINE; NIMODIPINE; VERAPAMIL;

CELL DEATH; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GENETIC ASSOCIATION; GLAUCOMA; GLAUCOMA SURGERY; HIGH TENSION GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; NERVE INJURY; NEUROPROTECTION; NORMAL TENSION GLAUCOMA; OPEN ANGLE GLAUCOMA; OPTIC NERVE; OPTIC NERVE DISEASE; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; RISK FACTOR; TRABECULOPLASTY; VISUAL IMPAIRMENT;

AGED; CORNEA; DISEASE PROGRESSION; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; OPTIC DISK; PATIENT COMPLIANCE; RISK FACTORS; TOMOGRAPHY; VISUAL FIELDS;

EID: 53049091844     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)01114-X     Document Type: Review

References (56)

1. AGIS (Advanced Glaucoma Intervention Study) Investigators. The advanced glaucoma intervention study: 8. Risk of cataract formation after trabeculectomy. Arch. Ophthalmol. 119 12 (2001) 1771-1779
2. Allingham R.R., Damji K., Freedman S., Moroi S., Shafranov G., and Shields M.B. Chronic open-angle glaucoma and normal-tension glaucoma. In: Pine J., and Murphy J. (Eds). Shields' Textbook of Glaucoma. 5th edition (2005), Lippincott Williams & Wilkins, Philadelphia, PA 197-207 Chapter 11
3. Alward W., Kwon Y., Kawase K., Craig J., Hayreh S., Johnson A., Khanna C., Yamamoto T., Mackey D., Roos B., Affatigato L., Sheffield V., and Stone E. Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma. Am. J. Ophthalmol. 136 (2003) 904-910
4. American Glaucoma Society. Patient Care Improvent Project: Pearls to Improve Patient Compliance. http://www.glaucomaweb.org/associations/5224/files/02Booklet_Pearls.F.pdf
5. Bose S., Piltz J.R., and Brenton M.E. Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with NTG and in control subjects. Ophthalmology 102 8 (1995) 1236-1241
6. Butt Z., McKillop G., O'Brien C., Allan P., and Aspinall P. Measurement of ocular blood flow velocity using color Doppler imaging in low tension glaucoma. Eye 9 Pt 1 (1995) 29-33
7. Caprioli J. The treatment of normal-tension glaucoma. Am. J. Ophthalmol. 126 4 (1998) 578-581
8. Caprioli J., and Spaeth G.L. Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas. Am. J. Ophthalmol. 97 (1984) 730-737
9. Caprioli J., and Spaeth G.L. Comparison of the optic nerve head in high- and low-tension glaucoma. Arch. Ophthalmol. 130 (1985) 1145-1149
10. Cartwright N.J., and Anderson D.R. Correlation of asymmetric damage with asymmetric intraocular pressure in NTG (low tension glaucoma). Arch. Ophthalmol. 106 (1988) 898-900
11. Cartwright M.J., Grajewski A.L., Friedberg M.L., Anderson D.R., and Richards D.W. Immune-related disease and normal-tension glaucoma: a case-control study. Arch. Ophthalmol. 110 4 (1992) 500-502
12. Crichton A., Drance S.M., Douglas G.R., and Schulzer M. Unequal intraocular pressure and its relation to asymmetric visual field defects in low-tension glaucoma. Ophthalmology 96 (1989) 1312-1314
13. Cursiefen C., Wisse M., Cursiefen S., Junemann A., Martus P., and Korth M. Migraine and tension headache in high-pressure and normal-pressure glaucoma. Am. J. Ophthalmol. 129 (2000) 102-104
14. Drance S., Anderson D.R., and Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am. J. Ophthalmol. 131 (2001) 699-708
15. Friedman D.S., Nordstrom B., Mozaffari E., and Quigley H.A. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology 112 (2005) 1500-1504
16. Friedman D.S., Quigley H.A., Gelb L., Tan J., Margolis J., Shah S.N., Kim E.E., Zimmerman T., and Hahn S.R. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest. Ophthalmol. Vis. Sci. 48 (2007) 5052-5057
17. Gaasterland D.E., Allingham R.R., Gross R.L., Jampel H.D., Kwon Y.H., Prum B.E., and Gordon M.O. In: Garratt S. (Ed). American Academy of Ophthalmology. Primary Open-Angle Glaucoma, Preferred Practice Pattern (2005), San Francisco, American Academy of Ophthalmology 1-23 Available at www.aao.org/ppp
18. Geijssen H.C. Studies on Normal-Pressure Glaucoma (1991), Kugler, Amstelveen, The Netherlands
19. Graefe A.V. Uber die Iridectomie bei Glaucoma und über den Glaucomatösen Prezess. Albrecht von Graefes Archiv. Klin. Exp. Ophthalmol. 13 (1857) 456-650
20. Greenfield D.S., Liebmann J.M., Ritch R., and Krupin T. Visual field and intraocular pressure asymmetry in the Low-Pressure Glaucoma Treatment Study. Ophthalmology 114 3 (2007) 460-465 Low-Pressure Glaucoma Study Group
21. Greenfield D.S., Siatkowski R.M., Glaser J.S., Schatz N.J., and Parrish R.K. The cupped disc: who needs neuroimaging?. Ophthalmology 105 (1998) 1866-1874
22. Harrington D.E. The pathogenesis of the glaucoma field: clinical evidence that circulatory insufficiency in the optic nerve is the primary cause of visual field in glaucoma. Am. J. Ophthalmol. 47 2 (1969) 177-185
23. Harris A., Rechtman E., Siesky B., Jonescu-Cuypers C., McCranor L., and Garzozi H.J. The role of optic nerve blood flow in the pathogenesis of glaucoma. Ophthalmol. Clin. North Am. 18 3 (2005) 345-353
24. Hayreh S.S., Podhajsky P., and Zimmerman M.B. Beta-blocker eye drops and nocturnal arterial hypertension. Am. J. Ophthalmol. 128 3 (1999) 301-309
25. Hayreh S.S., Zimmerman M.B., Podhajsky P., and Alward W.L. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am. J. Ophthalmol. 117 5 (1994) 603-624
26. Hirooka K., Baba T., Fujimura T., and Shiraga F. Prevention of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucoma. Am. J. Ophthalmol. 142 (2006) 523-524
27. Kawano J., Tomidokoro A., Mayama C., Kunimatsu S., Tomita G., and Araie M. Correlation between hemifield visual field damage and corresponding parapapillary atrophy in normal-tension glaucoma. Am. J. Ophthalmol. 142 (2006) 40-45
28. Kim D.M., Hwang U.S., Park K.H., and Kim S.H. Retinal nerve fiber layer thickness in the fellow eyes of normal-tension glaucoma patients with unilateral visual field defect. Am. J. Ophthalmol. 140 (2005) 165-166
29. 2+-antagonist on visual field in low-tension glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 227 5 (1989) 408-412
30. Krupin T., Liebmann J.M., Greenfield D.S., Rosenberg L.F., Ritch R., and Yang J.W. The low-pressure glaucoma treatment study: study design and baseline characteristics of enrolled patients. Ophthalmology 112 3 (2005) 376-385
31. Kuehn M., Fingert J., and Kwon Y. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol. Clin. North Am. 18 (2005) 383-395
32. Lumme P., Tuulonen A., Airaksinen P.J., and Alanko H.I. Neuroretinal rim area in low tension glaucoma: effect of nifedipine and acetazolamide compared to no treatment. Acta Ophthalmol. (Copenh.) 69 3 (1991) 293-298
33. Mabuchi F., Tang S., Kashiwagi K., Yamagata Z., Iijima H., and Tsukahara S. The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma. Am. J. Ophthalmol. 143 (2007) 125-130
34. Martus P., Stroux A., Budde S., Mardin C., Korth M., and Jonas J. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma. Am. J. Ophthalmol. 139 (2005) 999-1009
35. Melamed S., Levkovitch-Verbin H., Krupsky S., and Treister G. Confocal tomographic angiography of the optic nerve head in patients with glaucoma. Am. J. Ophthalmol. 125 4 (1998) 447-456
36. Meyer J.H., Brandi-Dohrn J., and Funk J. Twenty four hour blood pressure monitoring in normal tension glaucoma. Br. J. Ophthalmol. 80 10 (1996) 864-867
37. Morad Y., Sharon E., Hefetz L., and Nemet P. Corneal thickness and curvature in normal-tension glaucoma. Am. J. Ophthalmol. 125 (1998) 164-168
38. Netland P.A., Grosskreutz C.L., Feke G.T., and Hart L.J. Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker. Am. J. Ophthalmol. 119 6 (1995) 694-700
39. Ngan R., Lam D.L., Mudumbai R.C., and Chen P.P. Risk factors for noncompliance with follow-up among normal-tension glaucoma suspects. Am. J. Ophthalmol. 144 2 (2007) 310-311
40. Nicolela M.T., Buckley A.R., Walman B.E., and Drance S.M. A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels. Am. J. Ophthalmol. 122 (1996) 784-789
41. Oguri A., Sogano S., Yamamoto T., and Kitazawa Y. Incidence of elevation of intraocular pressure over time and associated factors in normal tension glaucoma. J. Glaucoma 7 2 (1998) 117-120
42. Ong K., Farinelli A., Billson F., Houang M., and Stern M. Comparative study of brain magnetic resonance imaging findings in patients with low-tension glaucoma and control subjects. Ophthalmology 102 11 (1995) 1632-1638
43. Phelps C.D., and Corbett J.J. Migraine and low-tension glaucoma: a case-control study. Invest. Ophthalmol. Vis. Sci. 26 (1985) 1105-1108
44. Quigley H.A., Nickells R.W., Kerrigan L.A., Pease M.E., Thibault D.J., and Zack D.J. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 36 5 (1995) 774-786
45. Rojanapongpun P., Drance S.M., and Morrison B.J. Ophthalmic artery flow velocity in glaucomatous and normal subjects. Br. J. Ophthalmol. 77 (1993) 25-29
46. Romano C., Barrett D.A., Li Z., Pestronk A., and Wax M.B. Anti-rhodopsin antibodies in sera from patients with normal-pressure glaucoma. Invest. Ophthalmol. Vis. Sci. 36 10 (1995) 1968-1975
47. Schumann J., Orgul S., Gugleta K., Dubler B., and Flammer J. Interocular difference in progression of glaucoma correlates with interocular differences in retrobulbar circulation. Am. J. Ophthalmol. 129 6 (2000) 728-733
48. Shiose Y., Kitazawa Y., Tsukahara S., Akamatsu T., Mizokami K., Futa R., Katsushima H., and Kosaki H. Epidemiology of glaucoma in Japan: a nationwide glaucoma survey. Jpn. J. Ophthalmol. 35 2 (1991) 133-155
49. Simmons S.T., Coiffi G.A., Gross R.L., Myers R.L., Netland P.A., Samples J.R., Wright M.M., and Brown S.V. Open-Angle Glaucoma. In: Simmons S.T., and Murphy J. (Eds). American Academy of Ophthalmology, Basic and Clinical Science Course: Glaucoma, Section 10, Chapter 4 (2004), American Academy of Ophthalmology, USA 92-96
50. Stroman G.A., Stewart W.C., Golnik K.C., Cure J.K., and Olinger R.E. Magnetic resonance imaging in patients with low-tension glaucoma. Arch. Ophthalmol. 113 2 (1995) 168-172
51. The Collaborative Normal-Tension Glaucoma Study (CNTGS). Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. The Collaborative Normal-Tension Glaucoma Study Group. Am. J. Ophthalmol. 126 (1998) 487-497
52. The Collaborative Normal-Tension Glaucoma Study (CNTGS). The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. The Collaborative Normal-Tension Glaucoma Study Group. Am. J. Ophthalmol. 126 (1998) 498-505
53. Waldmann E., Gasser P., Dubler B., Huber C., and Flammer J. Silent myocardial ischemia in glaucoma and cataract patients. Graefes Arch. Clin. Exp. Ophthalmol. 234 10 (1996) 595-598
54. Wax M.B., Barrett D.A., and Pestronk A. Increased incidence of paraproteinemia and autoantibodies in patients with normal-pressure glaucoma. Am. J. Ophthalmol. 117 5 (1994) 561-568
55. Wiggs J.L. Genes associated with human glaucoma. Ophthalmol. Clin. North Am. 18 3 (2005) 335-343
56. Woo S., Park K., and Kim D. Comparison of localised nerve fibre layer defects in normal tension glaucoma and primary open angle glaucoma. Br. J. Ophthalmol. 87 (2003) 695-698